Skip to main content

Displaying 1181 - 1200 of 1557

Announced Actions for January 14, 2005

Date
The Commission has approved a petition for proposed divestiture received from General Electric Company (GE) and related to the FTC decision and order regarding GE’s acquisition of InVision...

Cephalon, Inc., and CIMA Labs, Inc.

The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order required Cephalon to grant Barr Laboratories, Inc. a fully paid, irrevocable license to make and sell a generic version of Cephalon's breakthrough cancer pain drug, Actiq, in the United States.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410025

Sanofi-Synthelabo and Aventis, In the Matter of

The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order, Sanofi must: 1) divest its Arixtra factor Xa inhibitor to GlaxoSmithKline, plc; 2) divest its key clinical studies for the Campto® cytotoxic colorectal cancer treatment to Pfizer, Inc. and 3) divest Aventis' contractual rights to the Estorra insomnia drug either to Sepracor, Inc. or to another Commission-approved buyer.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
041 0031
Docket Number
C-4112

Announced Actions for October 5, 2004

Date
Commission approval of final consent orders: Following a public comment period, the Commission has approved a final consent order in the matter concerning the Virginia Board of Funeral Directors and...

Piedmont Health Alliance, Inc., et al., In the Matter of

With an administrative complaint issued on December 22, 2003 the Commission charged Piedmont Health Alliance, Inc. with collectively setting prices it demanded for physician services with third party payers. According to the complaint, the physician-hospital organization entered into signed agreements on behalf of its member physicians to participate in all contracts negotiated and to accept the negotiated physician fees. The complaint further alleges that these practices eliminated price competition among physicians in the North Carolina counties of Alexander, Burke, Caldwell and Catawba. The complaint also names ten individual physicians who participated in the alleged price fixing services. On August 10, 2004, the organization and physicians agreed to settle charges. Also refer to settlement entered with Tenet Healthcare Corporation (Frye Regional Medical Center, Inc.).

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0210119i
Docket Number
9314

Announced Actions for September 24, 2004

Date
Commission filing of comments with the U.S. Department of Energy: The Commission filed comments with the U.S. Department of Energy (DOE) concerning the designation of National Interest Electric...

Generic Drug Marketers Settle FTC Charges

Date
Generic drug manufacturers Alpharma, Inc. and Perrigo Company will give up $6.25 million in illegal profits to settle Federal Trade Commission charges that their agreement to limit competition for...

Announced Action for August 6, 2004

Date
Commission authorization of staff amicus brief filing: The Commission has authorized the staff to file a joint amicus brief in Spano, et al. v. SAFECO Insurance Co. of America, et al., No 04-35313...

Southeastern New Mexico Physicians IPA, Inc., a corporation, and Barbara Gomez and Lonnie Ray, individually

A Roswell, New Mexico physicians’ association, Southeastern New Mexico Physicians IPA, settled charges that it and two of its employees entered into collective agreements among physician members on fees and refused to deal with health plans that did not accept the collective agreed-upon terms. According to the complaint, these practices increased the price of health care in the Roswell area. The consent order prohibits the IPA and its employees named in the consent from orchestrating agreements between physicians to negotiate with health insurance plans on behalf of any physician and deal or refuse to deal individually with any third party payer.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0310134
Docket Number
C-4113